ASCO’s conference, the 2020 Community Oncology Alliance Annual Conference, and other meets continue apace despite the COVID-19 pandemic. Conferences that have moved online are now presenting their findings virtually. Among them are a leadership panel addressing issues in cancer care, ASCO’s annual
Merck Working on Potential COVID-19 Vaccine, More
In this weeks' Innovation Partners BioBlog, experts share opinions on how the healthcare industry will change after the first wave of the COVID-19 crisis passes. CVS plans to open more testing centers and hopefully process 1.5 million tests per month, depending on laboratories and supplies. And
Updates from the Oncology World
This week, several advances in the oncology world brought new hope to patients suffering from lung and pancreatic cancer. Roche’s Tecentriq gained new first-line lung cancer use while a Roswell Park Team developed a two-pronged approach to pancreatic cancer that offers promise. Oncologists received
New COVID-19 Therapy Studies, Lung Cancer Genetic Risk, and More
A two-combo cancer therapy has received FDA authorization for clinical researchers at a cancer center to begin a safety and effectiveness study. New data may have identified a genetic risk for lung cancer. The Trump Administration earmarked more money for states to conduct additional COVID-19
Everything Old Is New Again: Testing Older Drugs in the Fight Against COVID-19
Many pharmaceutical companies are testing and repurposing older medications to battle COVID-19. The lengthy list includes beta-blockers, drugs to combat autoimmune diseases, and stem cell therapy. The FDA issued emergency clearance for Gilead’s remdesivir to be used in hospital patients with
Testing and Medications to Fight COVID-19
In this week’s Innovation Partners BioBlog, we sum up the week’s news about the many changes the healthcare industry is undergoing during the COVID-19 pandemic. The drive to reopen the United States economy will start in pharmacies as more pledge to increase access to COVID-19 tests. Organizations
Cancer Drug Updates in the News
In this week’s edition of the Innovation Partners BioBlog, we focus on updates from the world of cancer treatments. Despite many companies halting tests and clinical trials due to the COVID-19 pandemic, a few are reporting clinical trial results and the FDA has approved a treatment for advanced
Cancer Care in the Era of COVID-19
This edition of the Innovation Partners BioBlog looks at cancer care in the era of COVID-19. ASCO released guidelines to help hospitals apportion scarce resources among critically ill patients, including cancer patients, during the pandemic. A new approach to prostate cancer drugs may delay drug